Importantly, the expression of hepatic Adgrf1 and Scd1 mRNAs can be further increased in the livers of subjects with more severe NAFLD, contributing to its acceleration and aggravation. Here, SCD is linked to metabolic dysfunction-associated steatotic liver disease.